25 June 2019
The Firm’s attorneys continue to successfully defend the patent rights of major international pharmaceutical companies. This is the fourth pharmaceutical manufacturer (along with Novartis, Bayer, and BMS) that successfully sought legal redress in the Intellectual Property Court thanks to the Firm’s team
2 September 2016
Egorov Puginsky Afanasiev & Partners Ukraine team successfully defended interests of one of the world's largest pharmaceutical companies in a dispute with the State Intellectual Property Service of Ukraine (Patent office) on extension of patent term for medical product for of additional 3 years over standard 20 years’ term.
11 January 2016
Egorov Puginsky Afanasiev & Partners is pleased to announce new appointments: the Firm appoints Anna Numerova as Partner of Competition Practice in Moscow and Michael Copeland as a Partner in London. Further, Igor Schikow (Tax Practice), Alexey Andrusenko and Andrey Mashkovtsev (M&A and Corporate Practice), Roman Malovitsky (Banking & Finance, Capital Markets Practice) and Andrey Bashirov (Legislation and Public Policy Practice) have been appointed as Counsel in Moscow. Viktoriya Podvorchanska (Pharmaceuticals and healthcare), Arsen Miliutin (Domestic Litigation) and Oleksandr Maydanyk (Tax Practice) have been appointed as Counsel in Kyiv.
20 July 2012
Egorov Puginsky Afanasiev & Partners has successfully protected the reputation of Sanofi Aventis, one of the world's largest pharmaceutical companies, during a complex libel case against several Russian publishing houses.
22 November 2011
Egorov Puginsky Afanasiev & Partners has successfully represented Antiviral, a Russian pharmaceutical manufacturer, whose products include Antigrippin-Maximum and Antigrippin-ANVI, in a dispute with Natur Produkt International, in regards to the Intellectual Property rights of Antigrippin trademarks.